Alimta Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Alimta General Information

Description

Provider of injection, powder, lyophilized for Solution for Intravenous use based out in Indonesia.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Indonesia
Primary Industry
Other Devices and Supplies
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Corporate Office
  • Indonesia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alimta Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Alimta‘s full profile, request access.

Request a free trial

Alimta Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Alimta‘s full profile, request access.

Request a free trial

Alimta FAQs

  • Where is Alimta headquartered?

    Alimta is headquartered in Indonesia.

  • What industry is Alimta in?

    Alimta’s primary industry is Other Devices and Supplies.

  • Is Alimta a private or public company?

    Alimta is a Private company.

  • What is Alimta’s current revenue?

    The current revenue for Alimta is .

  • Who are Alimta’s investors?

    Lilly USA has invested in Alimta.

  • When was Alimta acquired?

    Alimta was acquired on 05-Feb-2024.

  • Who acquired Alimta?

    Alimta was acquired by Zuellig Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process